Form 4: Merit Medical Director Receives RSU Grant
Statement of Changes in Beneficial Ownership
Director Lonny J. Carpenter was granted 3,457 restricted stock units as part of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.
Summary
- Director Lonny J. Carpenter acquired 3,457 restricted stock units (RSUs) of Merit Medical Systems, Inc. (MMSI).
- The grant was issued under the company's 2026 Equity Incentive Plan.
- The RSUs are scheduled to vest on May 3, 2027, contingent upon continued service to the issuer.
- Following this transaction, the director's total beneficial ownership stands at 20,824 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
- Retention of key leadership personnel through multi-year vesting schedules.
Negatives
- Minor dilution of existing shareholders due to the issuance of new equity units.
Risks
- Vesting is subject to continued service, creating a dependency on the director's ongoing tenure with the company.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the medical device sector to ensure board alignment with long-term strategic goals.
Comparison to Industry Standards
- The use of RSU grants for board compensation is consistent with standard practices among mid-cap medical technology companies.
- Vesting periods of approximately one year for director equity are common in the industry to balance retention with performance incentives.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Lonny J. Carpenter appointed Brian G. Lloyd, Raul Parra Jr., and Matthew C. Fleming as attorneys-in-fact for SEC filings. | 10/03/2025 | Standard administrative procedure to facilitate timely regulatory compliance. |
Stakeholder Impact
- Shareholders: Minimal impact due to the small size of the equity grant relative to total outstanding shares.
Next Steps
- Vesting of the 3,457 RSUs on May 3, 2027.
Key Dates
| Date | Description |
|---|---|
| 10/03/2025 | Date of Power of Attorney execution. |
| 05/18/2026 | Date of RSU grant transaction. |
| 05/03/2027 | Vesting date for the granted RSUs. |
Keywords
Merit Medical Systems, MMSI, Form 4, Director Compensation, Restricted Stock Units, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.